How many total In Vitro Diagnostics companies are there?

As of Oct 2026, there are 3,197 active companies in In Vitro Diagnostics sector.

Which countries have the most In Vitro Diagnostics companies?

United States (1,715) has the highest number of In Vitro Diagnostics companies, followed by United Kingdom (288) and India (195).

How many In Vitro Diagnostics companies are funded?

As of Oct 2026, 2,211 companies in this sector have received funding.

Which company has raised the most funding in In Vitro Diagnostics sector?

As of Oct 2026, Freenome Health has secured $1.35B in funding, making it the highest-funded company in the In Vitro Diagnostics sector.

Which country has attracted the most investment in In Vitro Diagnostics companies?

With $20B in total funding, United States has attracted the most investment among In Vitro Diagnostics companies.

Who are the top investors in In Vitro Diagnostics companies?

The top investors in In Vitro Diagnostics companies by number of investments are HHS, Europa and EIC Fund

How much venture capital has In Vitro Diagnostics sector attracted?

In the last 10 years, venture capital firms have invested $13.5B in this sector.

How many unicorns has In Vitro Diagnostics sector produced?

Globally, there are 6 unicorns in In Vitro Diagnostics sector, to date.

In Vitro Diagnostics - 2026 Market & Investments Trends

Companies included in In Vitro Diagnostics sector

Companies developing assays on samples such as blood or tissue that have been taken from the human body for the diagnosis of various diseases.

Companies excluded in In Vitro Diagnostics sector

Traditional Diagnostic Technologies, Diagnostic Devices, In vivo Testing Technologies

Key Metrics

Total Companies

3.96K

Top Companies

Natera, Guardant Health & more

Total Funding

Funded Companies

Series A+ Companies

Series C+ Companies

Unicorns Created

IPOs

183

Acquisitions

344

Also known as

In Vitro Diagnostics Solutions or Advanced In Vitro Diagnostics

View complete details of this sector

The market map of In Vitro Diagnostics gives a visual overview of the sector, showing key business models, their interactions in the value chain, and industry evolution. Top 3 trending business models in In Vitro Diagnostics sector are Neurological Diagnostics, Veterinary In Vitro Diagnostics and Pan Cancer Analysis Tests.

Recent BlueBox/Industry Definition image of In Vitro Diagnostics

Here are some reports related to In Vitro Diagnostics sector:

Free

In Vitro Diagnostics - Sector Report

Edition: September, 2026 (76 Pages)

Premium

In Vitro Diagnostics Investor Landscape

Edition: March, 2025 (12 Pages)

View all reports related to In Vitro Diagnostics. Sign up today!

There are more than 3.96K companies in In Vitro Diagnostics. Natera is the top In Vitro Diagnostics company globally, ranked using Tracxn Score (what's this?).

Here are 5 of the top In Vitro Diagnostics companies globally:

Company	Description	Location	Founded	Current Stage	Private Funding Raised
Natera	Developer of cell-free DNA testing for oncology, women’s health, and organ health	Redwood City (United States)	2004	Public	$152M
Guardant Health	Developer of digital sequencing technology for cancer detection	Redwood City (United States)	2012	Public	$557M
GRAIL	Developer of a screening platform for circulating tumor DNA to detect cancer	Menlo Park (United States)	2016	Public	$2B
Molbio Diagnostics	Developer of point-of-care molecular diagnostic platform for infectious disease detection	Salcete (India)	2000	Public	$124M
Cepheid	Developer of molecular diagnostic testing solutions	Sunnyvale (United States)	1996	Acquired	$19.1M

Get a longer list of companies

Companies founded year-on-year in the In Vitro Diagnostics sector

19 new startups have been founded so far in 2026 in the In Vitro Diagnostics sector. 214 In Vitro Diagnostics startups were founded in 2017 - this is the most number of startups founded in any year in the last 10 years.

Total Number of Companies

Year	No. of companies
2026	19
2025	26
2024	52
2023	65
2022	84
2021	111
2020	180
2019	152
2018	186
2017	214

Companies founded across countries in the In Vitro Diagnostics sector

United States has 1,715 In Vitro Diagnostics startups, the most by any country, followed by United Kingdom which has 288 startups and India which has 195.

Total Number of Companies

Country	No. of companies
United States	1,715
United Kingdom	288
India	195
Germany	176
China	168
Canada	130
Israel	125
Sweden	97
France	94
South Korea	91

Stage-wise distribution of the In Vitro Diagnostics sector

Out of the total 3,963 In Vitro Diagnostics companies, 2,211 have secured funding. Among them, 959 have reached Series A or higher, and 719 to Series B or beyond.

Founded - 3,963

Funded - 2,211

Series A+ - 959

Series B+ - 719

Series C+ - 619

Company Stage	No. of companies
Founded	3,963
Funded	2,211
Series A+	959
Series B+	719
Series C+	619

Want to know more about In Vitro Diagnostics ? Signup and explore Tracxn for free

4K+ Total Companies
$43.8B+ Total Funding
2.2K+ Funded Companies
180+ IPOs
340+ Acquisitions

Total funding year-on-year in the In Vitro Diagnostics sector

The In Vitro Diagnostics sector saw a total funding of more than $29.4B in the last 10 years. The most amount of funding was in 2021 at more than $5.32B. There has been a total funding of $775M in 2026 till date.

Total Funding

Year	Total Funding
2026	$775M
2025	$2.36B
2024	$1.78B
2023	$1.23B
2022	$2.44B
2021	$5.32B
2020	$5.01B
2019	$3.53B
2018	$3.5B
2017	$3.44B

Total funding across countries in the In Vitro Diagnostics sector

In the last 10 years, In Vitro Diagnostics startups in United States have recieved the highest funding among all countries - $20B. China follows with $2.11B and United Kingdom with $797M.

Total Funding

Country	Total Funding
United States	$20B
China	$2.11B
United Kingdom	$797M
Israel	$448M
Spain	$409M
India	$216M
Germany	$207M
Sweden	$193M
France	$180M
Switzerland	$173M

Total funding amount raised by stage in the In Vitro Diagnostics sector

Over the last 10 years, the In Vitro Diagnostics sector have seen $690M into Seed Stage funding rounds, $8.59B into Early Stage funding rounds and $8.85B go into Late Stage funding rounds.

Funding Stage	Total Funding
Late Stage	$8.85B
Early Stage	$8.59B
Post IPO	$6.01B
Grant	$1.66B
Debt	$755M
Seed Stage	$690M
PE	$139M

Recent Funding Rounds in In Vitro Diagnostics

In the year 2026, till September 2026, In Vitro Diagnostics companies have raised $528M in equity funding across 66 rounds. In the same period last year (i.e. till September 2025), In Vitro Diagnostics companies had raised $827M across 75 rounds. So, 2026 has seen a 36.09% drop in funding in In Vitro Diagnostics companies as compared to 2025.

Here are some recent, important funding rounds in In Vitro Diagnostics:

Company	Round Raised	Amount Raised	Funding Date	Investors
Intelligent Mass Spec Solutions	Seed	6110	Sep 23, 2026	-
iPremom	Seed	1320	Sep 02, 2026	Amadeus Capital and 2 more
Retham Technologies	Seed	3850	Aug 28, 2026	Talents VC Fund and 2 more
MiRNDa	Seed	9324	Aug 28, 2026	Global Brain and 1 more
Craif	Series D	5996	Aug 18, 2026	Granite Asia and 4 more

See a more detailed list of funding rounds

HHS is the top investor in In Vitro Diagnostics companies based on number of companies invested.

Here are some top investors in In Vitro Diagnostics:

Investor	Location	Top Portfolio Companies
HHS	Washington, DC (United States)	Natera, Cepheid, Adaptive Biotechnologies and BillionToOne
Europa	Belgium	Caris Life Sciences, OpGen, MeMed and UDX
EIC Fund	Brussels (Belgium)	MeMed, UDX, Saga Diagnostics and Vitestro
National Science Foundation	Arlington (United States)	CytoVale, Prometheus Laboratories, CoreMap and Amplified Sciences
NIH	United States	Cepheid, Inflammatix, CND Life Sciences and Tasso

See a more detailed list of investors

In the year 2026, till September 2026, 13 acquisitions happened in In Vitro Diagnostics sector. Last year, in 2025, a total of 14 acquisitions happened in In Vitro Diagnostics sector.

Here are some recent, important acquisitions in In Vitro Diagnostics:

Company	Acquisition Type	Acquisition Date	Acquirers
Convergent Genomics	Business Acquisition	Sep 14, 2026	Veracyte
Abscint	Business Acquisition	Aug 10, 2026	Curium
Personalis	Business Acquisition	Jul 20, 2026	Tempus
Vesica Health	Business Acquisition	Jun 04, 2026	Photocure
Durin Life Sciences	Business Acquisition	May 12, 2026	NeuroVision

See a more detailed list of acquisitions

Acquisition trends in In Vitro Diagnostics

Here are the acquisition trends in In Vitro Diagnostics:

Total Number of Acquisitions

Year	No. of companies
2026	13
2025	14
2024	11
2023	16
2022	23
2021	32
2020	23
2019	20
2018	23
2017	24

In the year 2026, till August 2026, 3 IPOs happened in In Vitro Diagnostics sector.

Here are some recent, important IPOs in In Vitro Diagnostics:

Company	IPO Date	Exchange Symbol
Molbio Diagnostics	Aug 17, 2026	Bombay Stock Exchange (BSE), National Stock Exchange (NSE)
BioLab	Feb 19, 2026	National Association of Securities Dealers Automated Quotations (NASDAQ)
Souzhou Ribo Life Science	Jan 09, 2026	Hong Kong Exchanges (HKG)
BillionToOne	Nov 06, 2025	National Association of Securities Dealers Automated Quotations (NASDAQ)
NEXSEN BioTech	Oct 14, 2025	Australian Securities Exchange (ASX)

See a more detailed list of IPOs

Companies founded by alumni from top colleges in the In Vitro Diagnostics sector

Most number of In Vitro Diagnostics startups have been founded by alumni from Stanford University, Massachusetts Institute of Technology and Harvard University.

College	No. of companies
Stanford University	44
Massachusetts Institute of Technology	42
Harvard University	41
University of Cambridge	29
University of Oxford	28
University of California (Berkeley)	19
University of Pennsylvania	19
Cornell University	18
Harvard Business School	18
Tel Aviv University	18

Total funding in companies founded by alumni from top colleges in the the In Vitro Diagnostics sector

In the last 10 years, Stanford University graduates' In Vitro Diagnostics companies have raised the most funding among top colleges. University of Oxford alumni are second, and Cornell University alumni are third.

College	Total Funding
Stanford University	$3.4B
University of Oxford	$1.99B
Cornell University	$1.7B
Massachusetts Institute of Technology	$1.41B
University College London	$1.35B
Harvard University	$1.06B
University of Cambridge	$856M
Princeton University	$528M
Duke University	$502M
University of California (Berkeley)	$486M